The AI Summit speakers are hand-selected to deliver purpose-driven content that dives below the surface, challenge status quo, engage attendees in collaborative dialog, and provide practical information that can be implemented. Our speakers are thought leaders who are sure to facilitate insightful discussion.
Chief Medical Information Officer
The Christ Hospital Health Network
After completing his Internal Medicine residency at The Christ Hospital, he pursued a M.S. in clinical and translation research - Informatics track from the University of Cincinnati. Joined UC Physicians as a hospitalist and later the UC Center for Health Informatics where he participated in the I2B2 development and CCTST research requests intake. He later served as an assistant to the UC Health CMIO with Epic validation, implementation and optimization phases. He chaired the UC Internal Medicine clinical decision support workgroup. He become Epic certified physician builder and physician build analytics. He became board certified in the new field of Clinical Informatics by the American Board of Preventive Medicine in 2014. He has a CHIME CMIO Leadership Academy certification.
He is an adjunct assistant professor for the UC College of Medicine and taught the online master’s degree in health informatics for the UC College of Applied Health Sciences. He has hosted periodic undergrad student site visits from the Xavier Department of Health Services Administration and offers an elective in Clinical Informatics for physician residents at The Christ Hospital. He currently serves as the CMIO for The Christ Hospital Health Network since 2015.
Co-Director, Computational Medicine Center
Cincinnati Children’s Medical Center
Regulatory Head of Global Software Standards
Pat Baird works at Philips as the Head of Global Software Standards. Pat likes to think of his job as “Policy Engineering” – understanding the unmet needs (and frustrations) of regulators and developers, and working to develop standards, whitepapers, and training to meet those needs.
Past roles have included software developer, engineering manager, project manager, lead engineer, and most recently he was the Director of Risk Management at Baxter Healthcare. Drawing on 20 years’ experience in product development, he has published and presented over 50 papers regarding product development. He has an M.B.A. and a master’s in healthcare quality and patient safety from Northwestern University.
Consultant – Global Device Quality Assurance
In his current role, Bob authors global medical device quality standards and common quality practice documents. He also provides oversight to changes to the Lilly device QMS in order to support Lilly digital device initiatives (including Mobile Medical Applications). Bob also provides global device quality support with respect to medical device QMS auditing, risk management governance including medical device cybersecurity risk governance, product lifecycle management (PLM), and device regulatory surveillance. He has twice presented at past FDA/Xavier University Global Medical Device Conferences on MMA QMS and risk management.
He is a member of the AAMI Device Security Working Group responsible for drafting TIR97/Ed.1 Principles for medical device security – Post-market security management for device manufacturers. He has worked for Lilly for the past 15 years with prior extensive experience as a technical communication specialist in software, aerospace and manufacturing. He holds a bachelor of arts in journalism from Indiana University—Bloomington.
Executive Vice President
PROSYSTEM, an NSF International Company
Oliver Christ has been active in international standardization efforts for more than 25 years and co-founded PROSYSTEM with the late Dr. Jürgen Stettin in 1999. The company was acquired by NSF International in 2017. In Germany, Mr. Christ has served as chair or co-chair of national committees including Human Factors/Usability for Medical Devices, Risk-Management for Medical Electrical Equipment, and Software for Medical Devices and Networked Medical Systems. Mr. Christ represents Germany on international standard committees for programmable electrical medical systems, human factors, risk management, software life cycle processes, and risk management for IT-networks incorporating medical devices (published as IEC 80001-1:2010). In 2013 Mr. Christ became an international delegate for Germany for the AAMI/UL initiative UL 2800 on Interoperability for Medical Devices. He received the DKE Needle award in 2014.
Director, Office of Pharmaceutical Quality Operations, Office of Regulatory Affairs
Alonza Cruse is Director, Office of Pharmaceutical Quality Operations (OPQO) within the FDA Office of Regulatory Affairs (ORA). His office is responsible for all pharmaceutical quality inspections and investigations, working in conjunction with FDA’s Center for Drug Evaluation & Research (CDER) and Center for Veterinary Medicine (CVM). Additionally, Mr. Cruse continues to lead ORA’s pharmaceutical collaboration efforts under the program alignment initiative.
From 2013-2015 Mr. Cruse served as the Director (Acting) of the Office of Medical Products & Tobacco Operations (OMPTO) within ORA, overseeing activities such as Generic Drug User Fee Amendments (GDUFA) implementation, pharmacy compounding, and the development of a New Inspection Protocols Program (NIPP). From 2000-2015, Mr. Cruse was the Director, FDA’s Los Angeles District Office, where his responsibilities included providing executive leadership to implementing, managing and evaluating FDA's regulatory operations. Mr. Cruse first joined ORA in 1983 as a microbiologist. He received his bachelor of science degree in medical technology from York College (City University of New York).
Program Division Director, Division of Pharmaceutical Quality Operations III, ORA
Mr. Czabaniuk holds a B.S. degree in in environmental health and has 40 years of experience in public and private scientific organizations. Mr. Czabaniuk is currently serving as the FDA/ORA Program Division Director (PDD) for the Division of Pharmaceutical Quality Operations III. He is one of four national PDD’s responsible for pharmaceutical regulatory oversight in 13 Midwest states including, MI, IN, OH, KY, IL, MO, KS, NE, IA, MN, WI, SD, and ND.
Prior to joining the FDA in 2002, Mr. Czabaniuk was an independent consultant in the contract pharmaceutical testing industry. His primary responsibilities were laboratory management and the review of Pharmaceutical analytical data including finished product release and validations related to NDA/ANDA applications. Mr. Czabaniuk began his career in the environmental testing industry (18 years) where he held numerous scientific and managerial positions. Management positions included: Branch Manager, Laboratory Director, VP General Manager for a Division of three multi state environmental testing laboratories, and corporate QA Director for national network of 8 environmental/radiochemical laboratories. He also served as a Project Manager for: nuclear/chemical hazardous waste clean-up investigations; industrial wastewater/groundwater/surface water contamination studies; and source and ambient air pollution studies.
Professor of Anesthesiology, Surgery, Biomedical Informatics and Health Policy
Vanderbilt University School of Medicine
Dr. Jesse Ehrenfeld currently serves as Chair of the Board of Trustees of the American Medical Association. He is a Professor of Anesthesiology, Surgery, Biomedical Informatics and Health Policy at Vanderbilt University School of Medicine. He divides his time among clinical practice, teaching, and research. He also serves as Director of Education Research for the Vanderbilt Office of Health Sciences Education, Director of the Vanderbilt Program for LGBTI Health, and Associate Director of the Vanderbilt Anesthesiology & Perioperative Informatics Research (VAPIR) Division.
In addition to his work with the AMA, Dr. Ehrenfeld has served on the governing boards of the American Society of Anesthesiologists Resident Component, the Massachusetts Medical Society and the Illinois State Medical Society. He also served as speaker of the house of delegates of the Massachusetts Medical Society for six years.
Born in Wilmington, Delaware, Dr. Ehrenfeld is a graduate of Phillips Academy, Haverford College, the University of Chicago Pritzker School of Medicine and the Harvard School of Public Health. He completed an internship in internal medicine, a residency in anesthesiology and an informatics fellowship at the Massachusetts General Hospital.
A combat veteran who deployed to Afghanistan during both Operation Enduring Freedom and Resolute Support Mission, Dr. Ehrenfeld, for his work in capturing and supporting the lives of LGBTQ people, was recognized in 2015 with a White House News Photographers Association award and, in 2016, with an Emmy nomination. Dr. Ehrenfeld lives in Nashville with his husband, Judd Taback, and their son Ethan Ehrenfeld-Taback.
Sr. Clinical Systems Analyst
The Christ Hospital Health Network
Steve Frigon is a Senior Clinical Systems Analyst at The Christ Hospital in Cincinnati, Ohio. Specializing in Application Development, Data Integration and Data Management solutions in the Pharmaceutical and Healthcare industries for the past 21 years. In this position, Steve develops various technology strategies and adaptation techniques in the areas of interoperability, web services and Digital Health. His focus in the AI framework is on explicability, validation and adoption that stimulates the development of trust in Patients and Physicians alike.
Prior to joining The Christ Hospital, Steve was a Data Integration Consultant with HC Tech, Inc. and a Data Integration Manager at Mercy Health.
Data Science Practice Manager
Amazon Web Services
Kyle Johnson is a Data Scientist Manager with the AWS Machine Learning Solutions Lab. His work focuses on helping life sciences companies solve business problems using machine and deep learning techniques on the AWS platform. He has experience with a variety of healthcare datasets including claims/clinical records, medical images, and manufacturing sensor records. He has worked on machine learning projects with many of the world’s largest payers, providers, and life sciences companies. He is also an Adjunct Professor at Carnegie Mellon University.
David joined Pfizer in 2013 and currently focuses on the development and implementation of AI solutions. His former research was focused on Predictive Modeling and Automated Control which now combined with the latest AI technologies brings a hybrid perspective to the field. He holds several publications in high impact International Journals and three of them have been in the TOP25 Science direct list. Before joining Pfizer, David worked in other Industries such as aluminum (ALCOA) and renewable energy (Technological Institute of Energy). He completed his post-doc in the University of Manchester in UK and his Ph.D. in The Polytechnic University of Valencia in Spain. His solutions always try to find the balance between efficacy and efficiency with a close look at the business case.
Cindi Linville is the Director of Quality for Best Sanitizers, and has worked at Best Sanitizers for nine years. Prior to working at Best Sanitizers, Cindi was the Facility Quality Assurance Manager for Avnet. She has a degree in IT Security, Electrical Engineering, Organizational Management, and a Masters in Business Management. Overall, Cindi has worked in Quality for over 20 years. Cindi also has ASQ certifications as a Quality Engineer, Biomedical Auditor and in Pharmaceutical GMPs.
Chief Technology Architect
Novo Nordisk – Global IT - Manufacturing
Kasper is an industrial engineer with 20 plus years of experience within the biotech and pharmaceutical industry. A PMI certified PM, he is a SABSA security practitioner and member of the Danish Automation societies and Digital Transformation of Factories (DToF) board of directors. He has always worked in the GMP regulated industry with assignments including documentation, qualification and validation. Kasper’s specialties include Enterprise Architecture, Project Management, Innovation, Manufacturing Intelligence, with a high expertise in MES application, batch and process reporting plus general industrial IT/Automation including IoT.
Kasper is a graduate of Copenhagen Engineering College – Manufacturing Sc. And Technology.
Toni is the R&D Director and co-founder of Bigfinite, a cloud company that provides a big data and AI SaaS platform for the Biotech and Pharma industry. Since 1996 he has led software projects for international pharmaceutical companies covering the entire production process and supply chain and is on the scientific committee of the PDA Europe supporting innovation and technology.
Fellow, Regulatory Science
Boston Scientific Corporation
Mac McKeen has over 25 years of experience in the medical device industry in regulatory and quality roles focused on the development, clinical study, and regulatory approvals of cardiovascular devices and is currently a Fellow at Boston Scientific with previous leadership roles at Guidant, Medtronic, St. Jude Medical, Cardiac Science and Phillips Medisize.
He also serves as an Adjunct Professor at the University of Minnesota instructing a 4000 level course on medical device development and is also a Faculty Director within the College of Continuing and Applied Professional Studies. He is actively involved in advocacy and collaboration with the FDA through industry associations including AdvaMed, MDIC and Medical Alley. He holds a B.S. in industrial technology from Iowa State University and an M.B.A. from the University of Dallas and is RAC-certified.
Head of Enterprise Analytics
Walt is the driving force for Data Analytics at Takeda. His vision for an Enterprise Analytics Marketplace is unique to the industry and has positioned Takeda to be a leader in Digital Health for rare diseases. The Analytics Marketplace allows all Takeda employees that ability to analyze data to make data-driven decisions and integrate data into a model for connected care. Prior to joining Takeda, Walt was a Senior Partner with CSC Consulting where is was known as a leader in Data. In 2010, Walt conducted a special research project for CSC’s Leading Edge forum to look at the future of data. His 2011 report, “Data rEvolution,” foreshadows the explosion in Data Analytics that we all see today. Walt received his Ph.D. in neuroscience from the University of Pennsylvania where he conducted Vision Research and studied brain physiology and microcircuitry.
Electronic Registry Systems, Inc.
Rohit currently leads Electronic Registry Systems, Inc., a cancer informatics firm that is at the forefront of providing cancer programs nationwide with a valuable foundation of data and insights that provide for the best cancer care for every patient. He also serves as an Advisor/Board Member for several early stage companies and not-for-profit organizations.
Rohit has a successful track record as strategic global leader and change catalyst, leveraging digital innovation, commercial execution, and P&L management skills across Fortune 500, startup, and emerging growth organizations, most recently in healthcare. Notably, he’s led a healthcare technology startup from vision to capitalization to execution and eventual sale / exit to a Fortune 500 company.
Most recently, Rohit led the formation of the global Digital Health team at Baxter with responsibilities to drive innovative software-enabled solutions leveraging their med device portfolio. Prior to Baxter, Rohit had several roles with increasing responsibilities at Quest Diagnostics where he was responsible for successfully developing and growing a P&L delivering customer-facing healthcare analytics solutions across the ambulatory, acute and payer markets. He previously co-founded and led an ePrescribing healthcare software company that was subsequently acquired by Quest Diagnostics.
Data & Analytics Leader
The Christ Hospital Health Network
Director, Division of Digital Health, Office of Science of Technology
Bakul Patel is Director for Division of Digital Health, at the Center for Devices and Radiological Health (CDRH), at the Food and Drug Administration (FDA). Mr. Patel is responsible for providing leadership, development, implementing, execution, management and setting strategic direction and regulatory policy and coordinate scientific efforts for digital health, software and emerging technologies.
This includes responsibilities in leading the development on policies for mobile health, health information technology, cyber security, medical device interoperability, and medical device software.
Mr. Patel also led the creation of the globally harmonized regulatory framework for “software as a medical device” (SaMD) at the International Medical Device Regulators Forum (IMDRF). The concepts, principles and vocabulary created in harmonized regulatory framework has been used as a foundation in the European union, Japan, Canada, Brazil, Australia and USFDA.
Mr. Patel is the FDA liaison between the Federal Communications Commission (FCC) and the Office of the National Coordinator (ONC).
Mr. Patel is currently leading the effort for the agency in developing an innovative software precertification program in collaboration with all stakeholders to reimagine a regulatory approach for Digital health that that aims for patients and providers to have timely access to safe and effective digital health products.
Prior to joining FDA, Mr. Patel held key leadership positions in the telecommunications industry, semiconductor capital equipment industry, wireless industry and information technology industry. His experience includes Lean Six Sigma, creating long and short-term strategy, influencing organizational change, modernizing government systems, and delivering high technology products and services in fast-paced, technology-intensive organizations. Mr. Patel earned an M.S. in electronic systems engineering from the University of Regina, Canada, and an M.B.A. in international business from The Johns Hopkins University.
Director, Xavier Health
Dr. Marla A. Phillips joined Xavier University in 2008 as the Director of Xavier Health, where she leads initiatives with FDA officials and Pharmaceutical and Medical Device professionals. Marla began working in the pharmaceutical industry for Merck in 1996 where she took on roles of increasing responsibility, culminating in position of Head of Quality Operations at the Merck North Carolina facility. She holds a B.S. in chemistry from Xavier University, and a Ph.D. in organic chemistry from the University of North Carolina – Chapel Hill.
Account Executive – Life Sciences
Siemens PLM Software
Nick joined Siemens PLM in 2016 and is responsible for driving Digital Enterprise for Life Sciences companies; connecting a model-based Digital Twin with a collaborative Digital Thread.
Prior to Siemens, Nick managed the Safe Skin clinical program and patient support surfaces portfolio at Hill-Rom, using analytics and technology to help reduce “never events” in the hospital setting.
Earlier in his career, Nick worked for Siemens Industry in various marketing, strategy and analytics positions across the Digital Factory business.
He has an M.B.A. from Xavier University and B.S. in marketing and management from University of Cincinnati. He is active in Xavier Health programs including the CPQA team.
Vice President, Technology and Regulatory Affairs
Zach Rothstein is Vice President for Technology & Regulatory Affairs at the Advanced Medical Technology Association (AdvaMed). In this position, Zach advocates for medical device regulatory policies that are transparent, predictable, consistent, timely, and science-based, with an emphasis on U.S. Food and Drug Administration (“FDA”) and legislative activities. Zach’s particular areas of focus include digital health, medical device software, cybersecurity, labeling, and postmarket surveillance.
Prior to joining AdvaMed, Zach was Deputy Senior Counsel for Public Policy at Samsung Electronics where he was responsible for the company’s medical device and healthcare regulatory and policy issues. In this position, Zach counseled Samsung’s global business units through all stages of product development on U.S. regulations affecting digital health, Health IT, and medical devices. Zach also planned and executed the company’s FDA and healthcare regulatory and legislative policy objectives. While at Samsung, Zach served on the Board of Directors for the Personal Connected Health Alliance (formerly Continua) and the Consumer Electronics Association’s Health and Fitness Technology Division.
Prior to joining Samsung, Zach was an Attorney in the FDA and Healthcare practice at the law firm of Morgan, Lewis & Bockius LLP. In this role, Zach served as outside counsel to various healthcare companies on FDA and HHS regulatory, compliance, and enforcement matters.
Zach earned his J.D. from The Catholic University of America, where he was a Notes and Comments Editor of the Law Review, President of the Moot Court Board, and won first place and best brief awards at the 2009 National Telecommunications Moot Court Competition. Zach received his B.A. in political science and criminal justice from Indiana University, Bloomington.
Zach is an active member of the Food and Drug Law Institute, teaches an introduction to FDA law class at the Johns Hopkins University, and was recognized by i3 magazine as a digital health and fitness innovator.
AI Research Technologist
Michael is a Technical Evangelist providing vision and leadership through transformational AI initiatives. His experience in supply chain, manufacturing and services is foundational in communicating that contextualized analytics is key to #datamonetization. Michael’s passion is demonstrating real-world scenarios with the Dell SupportAssist Intelligence Engine to explain that predictive and proactive AI platforms running at the “speed of thought” are feasible for every industry. Michael has been granted 12 hardware and software patents in eight countries.
Danny Tobey is a medical doctor and software entrepreneur who represents life sciences, technology and healthcare clients in all manner of disputes, from tort and contract claims to regulatory and patent cases. He also advises life sciences companies and funds as outside general counsel. In 2019, Danny received a Burton Award from the Library of Congress recognizing "the best of the best writers in the legal profession" among the nation's top 1,000 largest law firms.
A graduate of Harvard College, Yale Law School, and UT Southwestern Medical School, Danny has litigated successfully some of his clients' most challenging and important cases. He designed the winning scientific case in the first Hatch-Waxman suit in the Eastern District of Texas. He obtained a unanimous reversal in federal appellate court in an R&D tax case of first impression, leading to a highly-cited published opinion and increasing his clients' tax refund from low-six to high-seven figures. He has successfully handled as lead counsel litigations arising from M&A transactions for a molecular diagnostics company and others. He has represented healthcare and hospital clients in matters ranging from credentialing and internal investigation to peer review and business tort claims.
Founder, President and CEO
Don Wright is the Founder, President and CEO of Clarigent Health. Clarinet is bringing science to mental health by developing a system using artificial intelligence and machine learning technologies to study a person’s language and speech patterns to detect warning signs of distress, suicide ideation, and other types of mental health issues such as depression and anxiety. Using a smartphone-based app and server-based algorithms, individuals may be identified with a simple six-minute interview.
Prior to Clarigent, Don Wright spent a decade growing Assurex Health from technology invented at Mayo Clinic and Cincinnati Children’s Hospital Medical Center to a company of nearly 500 employees serving over 1,250,000 people with mental health conditions. Assurex Health was acquired in 2016 by Myriad Genetics allowing Don to use his more than 25 years of experience in the informatics, product development, operations and life sciences fields, to assisting others turn their ideas into hyper-growth companies.
Before Assurex Health, Don was co-founder and CTO of SaaS Capital, a specialty finance company serving the SaaS enterprise software application market. He has also served as Vice President of Global Product Development at Attachmate Corporation, directing a product development team of almost 1,000 professionals worldwide that served over 65,000 customers and accounts in nearly all the Global 10,000 enterprises. Don has previously held positions as Vice President and CTO for Spotlight Solutions and Vice President and CIO for Domin-8 Enterprise Solutions, both located in Mason Ohio. He is member of the board of directors of Include Fitness and Inagene Diagnostics and a member of the board of advisors of the NKU Center for Innovation and Entrepreneurship, the University of Cincinnati Business Analytics & Information Systems, and Cincinnati Children's Hospital Digital Health and Care.
Mark is a consultant with PwC's Health Industries Advisory practice based out of the San Francisco office. He has experience working with pharmaceutical and medical device companies to complete programs in quality system design and implementation in the U.S., India, and Ireland, post-merger integration, deals due diligence, and organizational assessments. Mark joined PwC with a background in neural engineering and clinical radiology laboratories. Mark holds a Bachelor of Science in Biomedical Engineering and a Master of Science in Biomedical Engineering from the University of Southern California.